Sanofi India Limited
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, S… Read more
Sanofi India Limited (SANOFI) - Total Liabilities
Latest total liabilities as of December 2025: ₹5.06 Billion INR
Based on the latest financial reports, Sanofi India Limited (SANOFI) has total liabilities worth ₹5.06 Billion INR as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sanofi India Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Sanofi India Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sanofi India Limited Competitors by Total Liabilities
The table below lists competitors of Sanofi India Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fujian Yongfu Power Engineering Co Ltd Class A
SHE:300712
|
China | CN¥2.83 Billion |
|
Nantong Haixing Electronics Co Ltd
SHG:603115
|
China | CN¥950.01 Million |
|
Tong Ren Tang Technologies Co. Ltd
PINK:TGRNF
|
USA | $4.24 Billion |
|
Sinostar Cable Co. Ltd.
SHE:300933
|
China | CN¥2.22 Billion |
|
Shenzhen Etmade Automatic Equipment
SHE:300812
|
China | CN¥692.26 Million |
|
enCore Energy Corp.
V:EU
|
Canada | CA$164.15 Million |
|
Hyster-Yale Materials Handling Inc
NYSE:HY
|
USA | $1.51 Billion |
|
Zhejiang Yankon Group Co Ltd
SHG:600261
|
China | CN¥1.55 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Sanofi India Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sanofi India Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sanofi India Limited (2004–2025)
The table below shows the annual total liabilities of Sanofi India Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₹5.06 Billion | -32.69% |
| 2024-12-31 | ₹7.51 Billion | +7.38% |
| 2023-12-31 | ₹7.00 Billion | -12.10% |
| 2022-12-31 | ₹7.96 Billion | -4.73% |
| 2021-12-31 | ₹8.35 Billion | +4.49% |
| 2020-12-31 | ₹8.00 Billion | -0.32% |
| 2019-12-31 | ₹8.02 Billion | +4.89% |
| 2018-12-31 | ₹7.65 Billion | +1.88% |
| 2017-12-31 | ₹7.51 Billion | -6.69% |
| 2016-12-31 | ₹8.04 Billion | +3.47% |
| 2015-12-31 | ₹7.77 Billion | +4.81% |
| 2014-12-31 | ₹7.42 Billion | +48.92% |
| 2013-12-31 | ₹4.98 Billion | +16.60% |
| 2012-12-31 | ₹4.27 Billion | +10.69% |
| 2011-12-31 | ₹3.86 Billion | -2.11% |
| 2010-12-31 | ₹3.94 Billion | +44.13% |
| 2009-12-31 | ₹2.74 Billion | +15.80% |
| 2008-12-31 | ₹2.36 Billion | +13.19% |
| 2007-12-31 | ₹2.09 Billion | -16.52% |
| 2006-12-31 | ₹2.50 Billion | +46.23% |
| 2005-12-31 | ₹1.71 Billion | +14.30% |
| 2004-12-31 | ₹1.50 Billion | -- |